Xultophy as a simple and effective substitute of intensive insulin therapy and a way of type 2 diabetes treatment deintensification
2020
Abstract
The case report describes a 66-year-old construction engineer, socially and professionally active, who was diagnosed with type 2 diabetes 15 years ago. He was 63 years old when the therapy with Xultophy was initiated.
The reason for the change in therapy was his long-termunsatisfactory diabetes control despite the intensive insulin regimen and oral antidiabetic combination therapy. The patient's obesity, his active lifestyle and his willingness to increasehis daily physical activity were all taken into account when considering the change in his treatmen